Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Mitchell
Article
Long-Lasting Pandemic Trends That Might Surprise You
It is no surprise that the COVID-19 pandemic has changed much about the way we live and do business.
Mitchell
News Release
Mitchell and Car ADAS Solutions Team Up to Provide Enhanced Calibration Support
SAN DIEGO, CA—Mitchell, a leading provider of technology, connectivity and information solutions to the
Workers' Comp
News Release
Risk & Insurance: Why Nurse Case Managers Are the Perfect Champions for the Biopsychosocial Model in Workers' Comp
Nurse case managers have the experience and the will to take the lead in delivering the biopsychosocial model of injured worker recovery.
Workers' Comp
News Release
Industrial Commission of Arizona Adopts New Fee Schedule
Earlier this year, the Industrial Commission of Arizona (ICA) released a proposed fee schedule for the coming year and a public hearing was held on
Workers' Comp
White Paper
Cultural Humility: The Next Step in Delivering Quality Care to Culturally Diverse Communities
Workers' Comp
Article
Technology & tools for employee wellness
Employee absence can be costly for employers, whether it’s due to work-related illnesses and injuries or not.